Advertisement

Neurocritical Care

, Volume 1, Issue 1, pp 85–94 | Cite as

Partial antagonistic effect of adenosine on inverse coupling between spreading neuronal activation and cerebral blood flow in rats

Translational Research

Abstract

Introduction: Fundamental principles in the central nervous system are that primary depolarization of neurons causes hyperemia, whereas focal cerebral ischemia causes secondary neuronal depolarization. In rats, an exception to these rules was discovered recently in which primary neuronal depolarization led to focal cerebral ischemia via inverse coupling between neuronal metabolism and cerebral blood flow (CBF). Adenosine is one of the classical candidate factors to mediate the coupling between neuronal metabolism and CBF. Therefore, the effect of topically applied adenosine on cortical spreading ischemia was studied.

Methods: A cranial window was implanted in 10 rats. At the window, CBF (laser Doppler flowmetry) and the subarachnoid direct current potential were recorded; the cortical surface was superfused with artificial cerebrospinal fluid (ACSF). A spreading neuronal/astroglial depolarization wave was triggered at a remote site, from which it propagated to the cranial window.

Results: In all rats, the depolarization wave triggered a hyperemic event under physiological conditions. When ACSF containing the nitric oxide (NO)-synthase inhibitor NG-nitro-l-arginine (l-NNA) at 10−3M and K+ at 20×10−3M was subsequently superfused, the depolarization wave triggered an ischemic event. In 5 of 10 animals, a second depolarization wave under l-NNA and elevated K+ also triggered an ischemic event. In contrast, in the remaining five animals, the depolarization wave triggered a significantly smaller and shorter hypoperfusion when adenosine at 100 µM was coapplied with l-NNA and elevated K+.

Conclusion: The results of this study suggest that adenosine, like other vasodilators, is unable to antagonize the initial hypoperfusion in response to a spreading neuronal/astroglial depolarization wave when the NO concentration is reduced and K+ is elevated but shortens the hypoperfusion phase significantly.

Key Words

Cortical spreading ischemia cortical spreading depression delayed ischemic neurological deficit subarachnoid hemorhage 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Villringer A, Dirnagl U. Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging. Cerebrovasc Brain Metab Rev 1995;7:240–276.PubMedGoogle Scholar
  2. 2.
    Leão AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944;7:359–390.Google Scholar
  3. 3.
    Dreier JP, Körner K, Ebert N, et al. Nitric oxide scavenging by haemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induce cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 1998;18:978–990.PubMedCrossRefGoogle Scholar
  4. 4.
    Dreier JP, Ebert N, Priller J, et al. Products of hemolysis in the subarachnoid space induce cortical spreading ischemia and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid haemorrhage? J Neurosurg 2000;93:668–676.Google Scholar
  5. 5.
    Dreier JP, Windmüller O, Petzold G, Lindauer U, Einhäupl KM, Dirnagl U. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine or moderate volume expansion/hemodilution in rats. Neurosurgery 2002;51:1457–1467.PubMedCrossRefGoogle Scholar
  6. 6.
    Dreier JP, Petzold G, Tille K, et al. Ischaemia triggered by spreading neuronal activation is inhibited by vasodilators in rats. J Physiol (Lond) 2001;531:515–526.CrossRefGoogle Scholar
  7. 7.
    Feigin VL, Rinkel GJ, Algra A, Vermeulen M, van Gijn J. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998;50:876–883.PubMedGoogle Scholar
  8. 8.
    Van Gijn J, Rinkel GJE. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001;124:249–278.PubMedCrossRefGoogle Scholar
  9. 9.
    Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke 1989;20:1511–1515.PubMedGoogle Scholar
  10. 10.
    Vermeij FH, Hasan D, Bijvoet HW, Avezaat CJ. Impact of medical treatment on the outcome of patients after aneurismal subarachnoid hemorrhage. Stroke 1998;29:924–930.PubMedGoogle Scholar
  11. 11.
    Rosenwasser RH, Delgado TE, Buchheit WA, Freed MH. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery 1983;12:658–661.PubMedCrossRefGoogle Scholar
  12. 12.
    Morii S, Ngai AC, Ko KR, Winn HR. Role of adenosine in regulation of cerebral blood flow: effects of theophylline during normoxia and hypoxia. Am J Physiol 1987;253:H165-H175.PubMedGoogle Scholar
  13. 13.
    Winn HR, Rubio GR, Berne RM. The role of adenosine in the regulation of cerebral blood flow. J Cereb Blood Flow Metab 1981;1:239–244.PubMedGoogle Scholar
  14. 14.
    Kaku T, Hada J, Hayashi Y. Endogenous adenosine exerts inhibitory effects upon the development of spreading depression and glutamate release induced by microdialysis with high K+ in rat hippocampus. Brain Res 1994;658:39–48.PubMedCrossRefGoogle Scholar
  15. 15.
    Ko KR, Ngai AC, Winn HR. Role of adenosine in regulation of regional cerebral blood flow in sensory cortex. Am J Physiol 1990;259:H1703-H1708.PubMedGoogle Scholar
  16. 16.
    Barfod C, Akgören N, Fabricius M, Dirnagl U, Lauritzen M. Laser-Doppler measurements of concentration and velocity of moving blood cells in rat cerebral circulation. Acta Physiol Scand 1997;160:123–132.PubMedCrossRefGoogle Scholar
  17. 17.
    Edvinsson L, Fredholm BB. Characterization of adenosine receptors in isolated cerebral arteries of cat. Br J Pharmacol 1983;80:631–637.PubMedGoogle Scholar
  18. 18.
    Fenton RA, Bruttig SP, Rubio R, Berne RM. Effect of adenosine on calcium uptake by intact and cultured vascular smooth muscle. Am J Physiol 1982;242:H797-H804.PubMedGoogle Scholar
  19. 19.
    Foley DH. Diminished arterial smooth muscle response to adenosine during Na-K pump inhibition. Pflugers Arch 1984;400:88–95.PubMedCrossRefGoogle Scholar
  20. 20.
    Dirnagl U, Niwa K, Lindauer U, Villringer A. Coupling of cerebral blood flow to neuronal activation: role of adenosine and nitric oxide. Am J Physiol 1994;267:H296-H301.PubMedGoogle Scholar
  21. 21.
    Armstead WM. Role of nitric oxide, cyclic nucleotides, and the activation of ATP-sensitive K+ channels in the contribution of adenosine to hypoxia-induced pial artery dilation. J Cereb Blood Flow Metab 1997;17:100–108.PubMedCrossRefGoogle Scholar
  22. 22.
    Kuo L, Chancellor JD. Adenosine potentiates flow-induced dilation of coronary arterioles by activating KATP channels in endothelium. Am J Physiol 1995;269:H541-H549.PubMedGoogle Scholar
  23. 23.
    Vials A, Burnstock G. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br J Pharmacol 1993;109:424–429.PubMedGoogle Scholar
  24. 24.
    Ngai AC, Winn HR. Modulation of cerebral arteriolar diameter by intraluminal flow and pressure. Circ Res 1995;77:832–840.PubMedGoogle Scholar
  25. 25.
    Colonna DM, Meng W, Deal DD, Busija DW. Nitric oxide promotes arteriolar dilation during cortical spreading depression in rabbits. Stroke 1994;25:2463–2470.PubMedGoogle Scholar
  26. 26.
    Wei EP, Kukreja R, Kontos HA. Effects in cats of inhibition of nitric oxide synthesis on cerebral vasodilation and endothelium-derived relaxing factor from acetylcholine. Stroke 1992;23:1623–1628.PubMedGoogle Scholar
  27. 27.
    Conde MV, Marco EJ, Fraile ML, et al. Different influence of endothelium in the mechanical responses of human and cat isolated cerebral arteries to several agents. J Pharm Pharmacol 1991;43:255–261.PubMedGoogle Scholar
  28. 28.
    Haberl RL, Anneser F, Villringer A, Einhaupl KM. Angiotensin II induces endothelium-dependent vasodilation of rat cerebral arterioles. Am J Physiol 1990;258:H1840-H1846.PubMedGoogle Scholar
  29. 29.
    Kraig RP, Nicholson C. Extracellular ionic variations during spreading depression. Neuroscience 1978;3:1045–1059.PubMedCrossRefGoogle Scholar
  30. 30.
    Nishiye E, Nakao K, Itoh T, Kuriyama H. Factors inducing endothelium-dependent relaxation in the guinea-pig basilar artery as estimated from the actions of haemoglobin. Br J Pharmacol 1989;96:645–655.PubMedGoogle Scholar
  31. 31.
    Minato H, Hashizume M, Masuda Y, Hosoki K. Modulation of extraluminally induced vasoconstrictions by endothelium-derived nitric oxide in the canine basilar artery. Arzneimittelforschung 1995;45:675–678.PubMedGoogle Scholar
  32. 32.
    Golding EM, Steenberg ML, Johnson TD, Bryan RM. Nitric oxide in the potassium-induced response of the rat middle cerebral artery: a possible permissive role. Brain Res 2001;889:98–104.PubMedCrossRefGoogle Scholar
  33. 33.
    Schuh-Hofer S, Lobsien E, Brodowsky R, et al. The cerebrovascular response to elevated potassium-role of nitric oxide in the in vitro model of isolated rat middle cerebral arteries. Neurosci Lett 2001;306:61–64.PubMedCrossRefGoogle Scholar
  34. 34.
    Duckrow RB. A brief hypoperfusion precedes spreading depression if nitric oxide synthesis is inhibited. Brain Res 1993;618:190–195.PubMedCrossRefGoogle Scholar
  35. 35.
    Hajek I, Subbarao KV, Hertz L. Acute and chronic effects of potassium and noradrenaline on Na+, K+-ATPase activity in cultured mouse neurons and astrocytes. Neurochem Int 1996;28:335–342.PubMedCrossRefGoogle Scholar
  36. 36.
    MacDonald RL, Weir BKA. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991;22:971–982.PubMedGoogle Scholar
  37. 37.
    Edwards DH, Byrne JV, Griffith TM. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg 1992;76:830–837.PubMedCrossRefGoogle Scholar
  38. 38.
    Pluta RM, Thompson BG, Dawson TM, Snyder SH, Boock RJ, Oldfield EH. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg 1996;84:648–654.PubMedGoogle Scholar
  39. 39.
    Ohta O, Osaka K, Siguma M, Yamamoto M, Shimizu K, Toda N. Cerebral vasospasm following ruptured intracranial aneurysms, especially some contributions of potassium ion released from subarachnoid hematoma to delayed cerebral vasospasm. In: Bevan JA, ed. Vascular Neuroeffector Mechanisms. New York: Raven, 1983:353–358.Google Scholar
  40. 40.
    Marzatico F, Gaetani P, Rodriguez y Baena R, et al. Experimental subarachnoid hemorrhage. Lipid peroxidation and Na(+),K(+)-ATPase in different rat brain areas. Mol Chem Neuropathol 1989;11:99–107.PubMedCrossRefGoogle Scholar
  41. 41.
    Birse SH, Tom MI. Incidence of cerebral infarction associated with ruptured intracranial aneurysms. A study of 8 unoperated cases of anterior cerebral aneurysm. Neurology 1960;10:101–106.PubMedGoogle Scholar
  42. 42.
    Stoltenburg-Didinger G, Schwarz K. Brain lesions secondary to subarachnoid hemorrhage due to ruptured aneurysms. In: Cervós-Navarro J, Ferszt R, eds. Stroke and Microcirculation. New York: Raven, 1987:471–480.Google Scholar
  43. 43.
    Neil-Dwyer G, Lang DA, Doshi B, Gerber CJ, Smith PW. Delayed cerebral ischaemia: the pathological substrate. Acta Neurochir (Wien) 1994;131:137–145.CrossRefGoogle Scholar
  44. 44.
    Dreier JP, Sakowitz OW, Harder A, et al. Focal laminar cortical MR signal abnormalities after subarachnoid hemorrhage. Ann Neurol 2002;52:825–829.PubMedCrossRefGoogle Scholar
  45. 45.
    Nosko M, Krueger CA, Weir BK, Cook DA. Effects of nimodipine on in vitro contractility of cerebral arteries of dog, monkey, and man. J Neurosurg 1986;65:376–381.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2004

Authors and Affiliations

  1. 1.Department of Experimental Neurology, CharitéUniversity Medicine BerlinGermany
  2. 2.Department of PsychiatryWenckebach HospitalBerlinGermany

Personalised recommendations